Identification of chaperones as essential components of the tumor rejection moieties of cancers.
Center for Immunotherapy of Cancer and Infectious Diseases, Department of Immunology, University of Connecticut School of Medicine, Farmington, CT, USA. srivastava@uchc.edu
Pramod K
PK
Srivastava
D000818:Animals; D000951:Antigens, Neoplasm / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D018832:Molecular Chaperones / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D017712:Peer Review, Research; D010455:Peptides / Q000276:immunology; D051381:Rats
D000951:Antigens, Neoplasm; D018832:Molecular Chaperones; D010455:Peptides; C052646:sarcoma glycoprotein gp96 rejection antigens